Some visit links earn us a commission.
Quick verdict
Mochi Health is the better pick for most patients on overall scoring. Flat monthly pricing, transparent compounded sourcing and no lock-in. Best fit for cash-pay patients who want predictable monthly billing.
That said, Embla wins on specific dimensions. Embla is the closest thing the US market has to a Noom-meets-Calibrate hybrid that actually leans into the medication. Heavy behavioral coaching, branded-first prescribing, structured 12-month curriculum. Best for buyers who want the program to do half the work.
Side-by-side
| Mochi Health | Embla | |
|---|---|---|
| Starts from | $178/mo (incl. medication) | $249/mo (+ med separate) |
| Monthly cost gap | Mochi Health is $71/mo cheaper than Embla | |
| Lock-in | Month-to-month | 12-mo lock-in |
| Time to prescription | 3 days | 7 days |
| Consultation type | Live | Live |
| Affiliate network | Impact | Impact |
Score by dimension
Scores out of 10, equal-weighted across five dimensions. How we score. The winner of each dimension is highlighted.
| Mochi Health | Embla | |
|---|---|---|
| Pricing transparency | 9/10 | 4/10 |
| Cancellation terms | 9/10 | 7/10 |
| Onboarding experience | 8/10 | 6/10 |
| Medication options | 6/10 | 7/10 |
| Member reviews | 9/10 | 9.2/10 |
When to choose Mochi Health
Best for flat predictable cash-pay
Cash-pay patients who want predictable monthly pricing and a compounded GLP-1 path.
Mochi Health wins on pricing transparency, cancellation terms, onboarding experience and runs $71/mo cheaper than Embla at the entry tier ($178 vs $249). Over a year that's $852 you keep. The caveat: Patients who specifically want FDA-approved branded Wegovy or Zepbound through insurance. Note also: Active in Lilly's 2025-2026 lawsuit against compounded tirzepatide pharmacies
When to choose Embla
Best for structured behavior support
Patients who tried meds-only and bounced, and want a structured behavior program alongside GLP-1.
Embla wins on medication options, member reviews on the dimensional scoring. The caveat: Buyers who only want the script and find coaching content patronizing.
If cost is your main filter
Mochi Health is the cheaper monthly: $178 all-in vs $249 for Embla. That's $71 a month or $852a year. The 12-month math matters most if you're planning to maintain on GLP-1 long-term. If you're running a 3-month trial, the $213 delta is small against the cost of stopping early on the wrong dose. Insurance changes the picture: if either program runs prior auth and your plan covers Wegovy or Zepbound, branded with copay can beat both cash-pay totals.
If lock-in is your main filter
Mochi Health (month-to-month) and Embla (12-mo lock-in) sit at different cancellation tiers. If you're first-time on a GLP-1 and unsure how you'll tolerate it, Mochi Health's easier cancellation is the safer trial.
FAQ
Is Mochi Health cheaper than Embla?
Can I switch from Mochi Health to Embla mid-treatment?
Which program has better member feedback?
Read the full reviews
All head-to-head comparisons → · Full chart → · Cost guide · Programs guide
